Main > CARDIOLOGY (**) > USA. P. HF. Symptomatic>**



USA. P. HF. Symptomatic>**'s subsections
(*) JP Approval Date: 2007. 07.31.
(*) USA Approval Date: 2002. 09.27.
>with HFrEF After AMI>Survival>
Company
Mechanism: Aldosterone AntAgonist
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 12
Patent>UpDate: 2009. 04.21.
Patent>USA Expiration: 2020
TradeMark JP
TradeMark USA
TradeMark USA Web-Site

USA. P. HF. Symptomatic>**'s products
This section has no products